Astera Labs, Inc. $ALAB Shares Bought by Alkeon Capital Management LLC

Alkeon Capital Management LLC lifted its position in Astera Labs, Inc. (NASDAQ:ALAB) by 30.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 325,000 shares of the company’s stock after acquiring an additional 75,000 shares during the period. Alkeon Capital Management LLC’s holdings in Astera Labs were worth $54,067,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Eurizon Capital SGR S.p.A. purchased a new position in shares of Astera Labs in the fourth quarter worth approximately $18,708,000. Nordea Investment Management AB purchased a new position in shares of Astera Labs in the fourth quarter worth approximately $2,028,000. Geneva Partners LLC purchased a new position in shares of Astera Labs in the third quarter worth approximately $1,876,000. Swedbank AB increased its position in shares of Astera Labs by 76.8% in the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after acquiring an additional 33,940 shares in the last quarter. Finally, Numerai GP LLC increased its position in shares of Astera Labs by 153.1% in the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after acquiring an additional 7,992 shares in the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Stock Performance

Shares of ALAB opened at $389.20 on Tuesday. The company’s 50 day moving average price is $242.61 and its 200 day moving average price is $180.88. Astera Labs, Inc. has a 52 week low of $84.78 and a 52 week high of $398.13. The company has a market capitalization of $66.71 billion, a PE ratio of 262.97, a PEG ratio of 4.86 and a beta of 3.94.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company’s revenue for the quarter was up 93.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on ALAB shares. Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Barclays boosted their price objective on shares of Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a research report on Thursday, May 7th. Needham & Company LLC boosted their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. TD Cowen boosted their price objective on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research report on Wednesday, May 6th. Finally, Evercore reaffirmed an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a research report on Tuesday, May 19th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and a consensus target price of $233.75.

Insider Buying and Selling

In other Astera Labs news, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the completion of the sale, the director directly owned 75,688 shares of the company’s stock, valued at $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total transaction of $1,277,046.75. Following the completion of the sale, the director directly owned 60,134 shares of the company’s stock, valued at $21,909,822.90. This represents a 5.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 2,161,256 shares of company stock valued at $459,844,296. 10.40% of the stock is owned by company insiders.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.